Skip to main
CTSH

CTSH Stock Forecast & Price Target

CTSH Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 14%
Buy 29%
Hold 57%
Sell 0%
Strong Sell 0%

Bulls say

Cognizant Tech Solns is positioned favorably because its strongest vertical, Financial Services, is still delivering double-digit growth through AI-driven modernization, large-deal execution, and wallet-share gains, while Health Sciences remains stable and CMT headwinds are easing. Despite the suspension of PERM filings in September and related cost pressure, the risk appears largely reflected in the share price, and management has multiple margin levers, including fixed-price contracts that now represent roughly half of revenue, workforce optimization, and Project LEAP. With $84 million incurred in Q2 on LEAP, the remaining $230–$320 million program costs spread through 2026 and benefits expected in FY27, the company’s improving operating margin path and strong free-cash-flow deployment support a constructive long-term outlook.

Bears say

Cognizant Tech Solns is facing a deteriorating fundamental backdrop as the suspension of the PERM program and broader scrutiny of visa usage threaten a core labor-arbitrage model that has long supported margins. With management already operating in a challenging regulatory environment aimed at curbing H1-B availability, the company may need to rely more heavily on higher-cost US talent while still expanding offshore hiring in India and other lower-cost regions. Its earnings power is also exposed to weak global economic growth, wage inflation, and foreign exchange risk, all of which can pressure revenue growth, profitability, and conversion of its large deal pipeline into profitable revenues.

CTSH has been analyzed by 14 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 29% recommend Buy, 57% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cognizant Technology Solutions and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cognizant Technology Solutions (CTSH) Forecast

Analysts have given CTSH a Buy based on their latest research and market trends.

According to 14 analysts, CTSH has a Buy consensus rating as of Oct 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $62.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $62.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cognizant Technology Solutions (CTSH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.